Lilly's currently approved injection, Zepbound, and Novo Nordisk's Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly's oral obesity pill, Foundayo, has delivered about 11% weight loss
Consultation A live video visit is required at Fridays
The strongest, proven benefits for skin come from topical application
Shima Hadidchi, MD, who can provide tailored treatment plans to suit your specific health goals
Advantages of Subdermal Application When applied topically, GHK-Cu must cross the outermost layer of the skin, the stratum corneum
It helps increase ceramide production, which improves your skins ability to hold moisture